NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Food & Drug Law Weekly


Susan Hasty, Publisher
Table of Contents . . . December 5th, 2008
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Food & Drug Law Weekly | Other Publications

Drug Development - U.S. Files Suit Against New Jersey Generic Drug Manufacturer That Distributed Adulterated and Misbranded Products

Food and Drug Law Institute - FDLI Names 2009 Distinguished Service and Leadership Award Recipients

Mental Health - Scientists at University of Greenwich target mental health

Merck & Co., Inc. - GARDASIL, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study

Osteoporosis - Hagens Berman Files Class Action Against Bayer Healthcare Over Misleading Marketing Campaign

Osteosarcoma - IDM Pharma Receives Recommendation for Approval of Mifamurtide (MEPACT(R), L-MTP-PE) for the Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma in Eu

Patents - Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray Patent Litigation

Allergies Immunology - Research results from Norwegian Institute of Public Health, Division of Environmental Medicine update knowledge of allergies immunology

Alzheimer Disease - Accera Will Launch Axona, New Approach to Managing Alzheimer's Disease, in 2009

Alzheimer Disease - More Than 2,000 New Medicines in Development for Older Americans

Ardea Biosciences, Inc. - Ardea Biosciences Announces Progress of Clinical Development Programs and Reports Third Quarter and Year-to-Date 2008 Financial Results

Arpida Ltd. - Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome

Ascent Healthcare Solutions - Ascent Receives Only 510k Clearance for Reprocessed Biosense Webster LASSO Variable Circular Mapping Catheters

Astigmatism - Studies by D.R. Sanders and co-authors describe new findings in astigmatism

Better Living Brands Alliance - Pioneering Supplements Manufacturer Enzymatic Therapy Joins Better Living Brands Alliance

Bioenergy, Inc. - Bioenergy D-Ribose Achieves Highest Safety Standard

Biopsy - Naviscan Receives 510(k) Clearance for Stereo Navigator(TM) - the First Commercially Available Breast PET-Guided Biopsy Feature

Breast Cancer - Brigham and Women's Hospital Enrolling Patients in Clinical Study to Test Non-Invasive, Radiation-Free Procedure to Relieve Pain from Bone Metastases

Cancer - Delcath Systems Granted Orphan-Drug Designations for Cutaneous and Ocular Melanoma

Cancer Clinical Trial - New cancer clinical trial findings from SAIC-Frederick, Inc. published

Cancer Vaccines - Mexican Department of Public Health to Launch Screening for Papillomavirus, Cause of Cervical Cancer

Caraco Pharmaceutical Laboratories, Ltd. - Caraco Pharmaceutical Laboratories, Ltd. Update on FDA Warning Letter

Chevron Energy Solutions - U.S. Army, Chevron and Keenan Development Receive 2008 National Council for Public-Private Partnerships' Infrastructure Award

Clinical Trial Research - Duska Therapeutics Applies for Phase 3 Special Protocol Assessment

Critical Path Institute - C-Path Expands Partnerships to Speed Development of Critical New Drug Therapies

Diabetes - Findings from C.M. Toscano and co-authors broaden understanding of diabetes

Drug Safety - United BioSource Scientists, FDA, and Other Industry Leaders Present to Risk Management and Drug Safety Summit

Epilepsy - FDA Approves BANZEL(TM) (rufinamide) as Adjunctive Treatment for Severe Epilepsy Disorder

Escherichia Coli - Studies from Texas A&M University describe new findings in Escherichia coli

Food Poisoning - USFoodSafety.com, a One-Stop Source for the Latest Food Recalls, Alerts, Food Safety Articles and Professional Food Safety Practices, Launches Today

Gen-Probe - Promising Clinical Data on Gen-Probe's APTIMA HPV Test Presented at Major European Medical Meeting

GlaxoSmithKline - FDA Approves Promacta Eltrombopag, the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder

Hair Loss - How the Economy is Changing the Hair Loss Treatment Industry

Hematologic Disease - Studies from University of Nebraska yield new data on hematologic disease

HIV/AIDS - Long-Term TITAN Study Evaluates PREZISTA(R)/ritonavir vs. lopinavir/ritonavir as Part of HIV Combination Therapy in Treatment-Experienced Adults

HIV/AIDS - Research on HIV/AIDS discussed by scientists at University of Massachusetts, Medical Department

Hypertension - FREEDOM-C Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Fails to Meet Primary Endpoint

Immunization - Research findings from J. Lu et al update understanding of immunization

Life Sciences - Data on life sciences published by J.C. Ornberg and colleagues

Life Sciences - New life sciences study findings have been reported by researchers at Catholic University

Life Sciences - New life sciences study findings have been reported by researchers at National Institute of Public Health and the Environment

Life Sciences - Reports from Radboud University add new data to research in life sciences

Life Sciences - Researchers at University of Michigan target life sciences

Lower Back Pain - Neuromed Completes Enrollment for Phase 3 Chronic Low Back Pain Clinical Trial of NMED-1077

Marketing and Licensing Agreements - American HealthChoice Announces the First Sales of the OmniBody Scan

Non-Small Cell Lung Cancer - Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer Therapy - Researchers from Harvard University, Center for Molecular Therapeutics report recent findings in non-small cell lung cancer therapy

Ovarian Cancer - Ortho Biotech Announces NDA Submission for Trabectedin for the Treatment of Relapsed Ovarian Cancer

Parkinson Disease - Mayo Clinic Develops Potential New Therapy to Stop the Progression of Parkinson's Disease

Pathology - Investigators at University of Texas target pathology

Pharmacology - Research from Hamline University broadens understanding of pharmacology

Poliomyelitis - Investigators at Indiana University target poliomyelitis

Protease - Scientists at University of Queensland detail research in protease

Regulatory Actions - Arpida Announces Posting of Briefing Documents for FDA Anti-Infective Drugs Advisory Committee Meeting on iclaprim

Regulatory Actions - Innocoll Receives Fast Track Designation for Gentamicin Surgical Implant

Regulatory Actions - Investigators at Queen's University zero in on regulatory actions

Regulatory Actions - Mortara Instrument Announces Extension of ECG Warehouse CRADA With US FDA

Regulatory Actions - Mylan Receives Final FDA Approval for the Generic Version of the Antidepressant Sarafem(R) Pulvules(R) Capsules

Regulatory Actions - Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase

Schizophrenia Epidemiology - Research from National Institute of Health and Medical Research in schizophrenia epidemiology provides new insights

Schizophrenia Therapy - Investigators at University Diego Portales release new data on schizophrenia therapy

Skin Cancer - Panel Demands FDA Action to Address Dramatic Increases in Skin Cancer in U.S.

Stanford University Medical Center - New imaging technique tracks cancer-killing cells over prolonged period

Vaccines - GeneThera Releases Results From Initial Animal Tests of E.Coli O157:h7 Vaccine Amid News of Increase of E.Coli Discoveries in Beef Products

West Nile Virus - Research on west nile virus published by A. Pai et al

Xytis, Inc. - Xytis to Initiate First-In-Class Phase I Clinical Trials with Alpha 7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator XY4083

Yersinia - New yersinia study findings reported from University of Washington



Return to Top of Page

-----------------------
PR Login